Trials / Sponsors / Japan Breast Cancer Research Group
Japan Breast Cancer Research Group
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC Metastatic Breast Cancer | Phase 2 | 2024-09-13 |
| Completed | A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Tr Breast Cancer | Phase 3 | 2017-08-28 |
| Completed | A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Can HER2-positive Locally Advanced or Metastatic Breast Cancer | Phase 3 | 2015-08-01 |
| Completed | Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Canc Metastatic Breast Cancer | Phase 2 | 2014-01-01 |